effects that limit therapeutic efficacy. To counter these problems, a wide range of complex nanocarriers have been explored as vectors for drug delivery, protecting delicate cargos from rapid degradation and enabling cargo delivery directly into cells, in addition to supporting imaging and sensing applications. [1][2][3] Among the wide range of options, zeolitic imidazolate frameworks (ZIFs) in particular have emerged as a promising, tunable materials platform in this field. [4][5][6][7] ZIFs represent a subset of metalorganic frameworks (MOFs) materials, that possess zeolite-like topologies and are built from imidazole-based organic linkers. Importantly, imidazole-based linkers are a broad family with varied chemistry, allowing tunability, facilitating larger porosity than in traditional zeolitic materials, and increased chemical tunability due to the variety of imidazole derivatives available. A rich family of related ZIF frameworks has been developed over the years, highlighting increased overall structural and chemical diversity. [8][9][10][11] While much of their chemical diversity in ZIFs has focused on other applications, [12] ZIFs are also well suited for biological applications owing to the high biocompatibility of both starting reagents, zinc metal, and imidazolate organic linkers. [13][14][15] Due to their biocompatibility, a large body of work exists concerning both encapsulation of cargo and drug delivery using ZIF nanoparticles, but the field is limited by the almost universal use of the prototypical ZIF-8, a material derived from a 2-methyl imidazole linker resulting in the sod topology. [4,5,7] As highlighted above, between different imidazole chemistries and different topologies, there are many known ZIF structures that have never been applied to the biological realm as well as novel ZIF structures that remain unexplored. Moreover, recent developments demonstrated rational ways of targeting novel, highly intricate zeolitic structures with extra-large cages, based on the size and shape of the imidazole-based linkers use in the synthesis. [9] Given the diversity of ZIF structures available, a significant opportunity exists to expand the functional space of ZIFs available for biological use. The implementation of distinct topologies would allow for the targeted use of hierarchical pore sizes, along with the introduction of more than one chemical functional group via the imidazole linker. These factors alter the dynamics of cargo encapsulation and release, both in Advanced therapeutics require novel nanocarriers to ensure their functionality is preserved during transit. Zeolitic imidazolate frameworks (ZIFs) have emerged as promising materials in this field owing to their combined biocompatibility, high porosity, and tunable chemistry. While a diverse family of ZIFs has been reported, few have been explored beyond the prototypical ZIF-8. Herein, the size-controlled synthesis of three distinct ZIF-76 analogs is demonstrated, overcoming the unique synthetic challenges intrinsic to the lta topology and ...